A wave of tenacity, a wave of hard work! GL Biochem spent only the first nine months of this year on finishing the journey which was taken 12 months of last year for her to reach!

The third-quarter sales summary meeting was held in the afternoon on 14 Oct, and the sales teams showed good results. The company’s overall sales increased by 44.2% year-on-year, approaching the sales figure of the entire year of last year. In the past few years, the company has experienced a series of challenges, but relying on a large number of outstanding talents who will never leave, ushered in a rare big development in the company’s history!

The subsidiaries Wuxi Asiapeptide Biotechnology Co. Ltd’s sales increased by 64% year-on-year, and Wuxi Mimotopes’s sales increased by 89% year-on-year in the third quarter. Adding the sales of these two companies together showed a year-on-year increase of 75% in the third quarter; for the total sales figure of January to September 2021, Wuxi Asiapeptide Biotechnology Co. Ltd company’s sales increased by 55% year-on-year, Wuxi Mimotopes company’s sales increased by 151% year-on-year, combine the two companies together, their sales of January to September 2021 increased 87% year-on-year.

GL’s other subsidiary Nanjing peptide company’s sales increased by 15.0% compared with the third quarter of last year. The total sales in the first three quarters increased by 53.6% over the first three quarters of last year. The most impressive achievement of Nanjing Peptide company is the 15 authorized patents obtained up until now this year!